Dynamically visualize your data.
Build stable, high-performance dashboards using REPT formulas and UNICHAR symbols instead of conditional formatting.
PD-1 inhibitors are equitably accessed across racial groups, with no significant differences in treatment patterns observed. Systemic chemotherapy remains the most common first-line treatment, despite ...
Ehlers–Danlos syndromes (EDS) are inherited conditions that affect the body's connective tissue, which provides strength and ...
Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system ...